InvestorsHub Logo
Followers 7
Posts 1577
Boards Moderated 0
Alias Born 02/27/2014

Re: None

Sunday, 05/17/2015 8:53:17 AM

Sunday, May 17, 2015 8:53:17 AM

Post# of 80868
It seems like Musclepharm is turning a corner where it can produce for higher revenues at a much more reasonable cost.

I think we are close to having adequate manufacturing capacity at Capstone Nutrition, and that a commercial bank loan soon will replace the loans through ANB bank.

Musclepharm may stil lose 20 cents in Q2, but the outlook will look much better.